BGB Securities Starts Bank of the Ozarks (OZRK) at Hold
Get Alerts OZRK Hot Sheet
Price: $41.24 --0%
Rating Summary:
7 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BGB Securities initiates coverage on Bank of the Ozarks (NASDAQ: OZRK) with a Hold. PT $35.00.
The firm comments, "We are initiating coverage of OZRK with a Hold rating and a $35 price target. We derive our target through our discounted dividend model, the application of a 14x multiple to forward EPS and OZRK's tangible book multiple of approximately 245% applied to our September 30, 2013 estimate of $5.34. Our 2012 and 2013 EPS estimates are $2.19 and $2.27, respectively."
For an analyst ratings summary and ratings history on Bank of the Ozarks click here. For more ratings news on Bank of the Ozarks click here.
Shares of Bank of the Ozarks closed at $33.13 yesterday.
The firm comments, "We are initiating coverage of OZRK with a Hold rating and a $35 price target. We derive our target through our discounted dividend model, the application of a 14x multiple to forward EPS and OZRK's tangible book multiple of approximately 245% applied to our September 30, 2013 estimate of $5.34. Our 2012 and 2013 EPS estimates are $2.19 and $2.27, respectively."
For an analyst ratings summary and ratings history on Bank of the Ozarks click here. For more ratings news on Bank of the Ozarks click here.
Shares of Bank of the Ozarks closed at $33.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share